They found that SCLC patients with high POU2F3 expression had a significantly increased ORR to immunotherapy (AUC = 0.813), and POU2F3 protein levels were positively correlated with patient prognosis (p = 0.022). Here, POU2F3 is linked to small cell lung carcinoma.